Benitec Continues to Work on Image as it Releases Financials for 1H of Fiscal 2004/2005 | GenomeWeb

Following its recent management shake up, it appears Benitec is taking advantage of every opportunity to reassure the world that its history of litigiousness is just that — history.

This week the company released its financial results for the first half of its fiscal year 2004/2005, and in an accompanying director’s report, Benitec’s new chairman Raymond Whitten stressed the company’s “increasing focus on drug development” and its move away from intellectual property litigation.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.

Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.

Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.

British researchers say they've been removed from EU grant applications, according to the Guardian.